KDM4B and diabetic kidney disease: Cyp4a14 KO mice have increased hypertension and develop diabetic nephropathy when treated with streptozotocin (STZ) compared to wild-type treated with STZ [49] and Kdm4b, a lysine demethylase, plays a role in regulating chromatin structure [50].